SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Kosan BioSciences -- KOSN
An SI Board Since May 2001
Posts SubjectMarks Bans Symbol
933 40 0 KOSN
Emcee:  tuck Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
208Geldanamycin seems to have applications beyond oncology: biotechjournal.com Chtuck-12/21/2002
207Daniel Santi, Why are you selling at a loss? insider.thomsonfn.com Do we needtuck-12/19/2002
206Dan Santi and Chaitan Khosla: The days of taking wealth out of biotech without scaram(o)uche-12/18/2002
205Kosan founders....... listen, <b>ASSHOLES</b>...... take you monescaram(o)uche-12/18/2002
204Another 8k sold by khosla. I see he has more shares today than in March (optionkeokalani'nui-12/18/2002
203And you wouldn't be left with a stockmarket. It's the shame gene that snigel bates-12/12/2002
202Breeding out the greed gene. I'm afraid you'll be fighting 3 billion yeDoc Bones-12/12/2002
201>> Not to white-wash it, but it looks like Santi hasn't sold any for ascaram(o)uche-12/12/2002
200Wish it had occurred after P2 commenced. Not to white-wash it, but it looks lkeokalani'nui-12/12/2002
199Rick Glad u made the comment on the insider sales. Its not only him who is selldalroi-12/12/2002
198Santi sells 60K shares, 12/4 and 12/5. ****<b>NOT COOL, DAN!!!</B>*scaram(o)uche-12/12/2002
197Parking here, as what they do looks similar to Kosan. (They are pretty tiny, butnigel bates-12/8/2002
196story.news.yahoo.com A Dirty Business Thu Dec 5, 6:36 PM ET By Robert Langrescaram(o)uche-12/6/2002
195Kaster files to sell 80,000 shares.mopgcw-11/26/2002
194celiac sprue research foundation files to sell 20,000 sharesmopgcw-11/22/2002
193EPOTHILONE DERIVATIVES AND METHODS FOR MAKING AND USING THE SAME Patent Numberscaram(o)uche-11/21/2002
192MOTILIDE COMPOUNDS Patent Number: Publication date: 2002-11-13 Inventor(sscaram(o)uche-11/21/2002
191Abstract 123: Phase I dose-escalating trial of KOS-862 (epothilone D) in patienkeokalani'nui-11/20/2002
190:-) It's sort of a joke, posting the clues in different places. You'llscaram(o)uche-11/20/2002
189How to become the perfect biotech trader?? tell me please ......... :-) Sdalroi-11/20/2002
188Interim Results from Phase 1 Trial of KOS-862 (Epothilone D) Presented at the Euscaram(o)uche-11/20/2002
187>> novartis has a competing product << That was my point. >>scaram(o)uche-11/19/2002
186nope, novartis has a competing product as novartis aquires roches normaly thedalroi-11/19/2002
185Wouldn't it be cool if they merged, were forced by various "regulatoriescaram(o)uche-11/19/2002
184>> Could it be an angle to make them less attractive to Novartis? <<scaram(o)uche-11/19/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News